NURS 6501 Week 2 Case Study Analysis Assignment Instructions

Analyzing symptoms of systemic lupus erythematosus in a young African American woman guides advanced practice nurses in understanding cellular pathophysiology for accurate diagnosis and patient education.

Case Study Analysis

An understanding of cells and cell behavior is a critically important component of disease diagnosis and treatment. Nurses often draw on this knowledge to better explain complex conditions to their patients.

But some diseases can be complex in nature, with a variety of factors and circumstances impacting their emergence and severity. Effective disease analysis often requires an understanding that goes beyond isolated cell behavior. Genes, the environments in which cell processes operate, the impact of patient characteristics, and racial and ethnic variables all can have an important impact.

An understanding of the signals and symptoms of alterations in cellular processes is a critical step in the diagnosis and treatment of many diseases. For APRNs, this understanding can also help educate patients and guide them through their treatment plans. Recent advancements in genomic research highlight how personalized approaches can improve outcomes.

In this Assignment, you examine a case study and analyze the symptoms presented. In 1-2 pages, you will answer the questions provided following the case scenario. You must use current evidence-based resources to support your answers. Follow APA guidelines. Follow the grading rubric. Integrating diverse patient factors ensures a holistic view of the condition.

Resources

Be sure to review the Learning Resources before completing this activity. Click the weekly resources link to access the resources.

WEEKLY RESOURCES

To prepare:

By Day 1 of this week, you will be assigned to a specific case study for this Case Study Assignment. Please see the “Announcements” section of the classroom for your assignment from your Instructor. Staying current with announcements helps avoid last-minute surprises.

The Assignment

Develop a 1- to 2-page case study analysis by answering the questions provided following the case scenario.

Week 2 Case Study

A 28-year-old African American woman presents with 4 months of worsening fatigue, joint pain, and intermittent low-grade fevers. She reports:

Symmetrical pain and stiffness in hands and wrists (morning stiffness ~1 hour)
Photosensitivity
Facial rash that worsens with sun exposure. Ongoing studies emphasize the role of environmental triggers in symptom exacerbation.
Hair thinning
Bilateral ankle swelling

No recent infection. No new medications.

Physical Examination

BP: 148/92 mmHg
Temp: 99.4°F
Erythematous malar rash sparing nasolabial folds
Tender MCP and PIP joints bilaterally. Modern diagnostic tools aid in identifying such patterns early.
Mild bilateral ankle edema

Laboratory Data

Test Result

Hgb 9.8 g/dL

WBC 3,000/mm³

Platelets 110,000/mm³

Creatinine 1.6 mg/dL

Urinalysis 2+ protein, RBC casts

ESR 65 mm/hr

ANA Positive (1:640)

Anti-dsDNA Elevated

Anti-Smith Positive

Complement C3/C4 Decreased

Questions:

Develop a 1- to 2-page case study analysis, examining the patient signs and symptoms presented in the case study; discussing the primary cellular pathophysiological processes, and the significance for symptom development and diagnosis. Emerging research on autoimmune markers provides deeper insights into these processes.
What role do genetic mutations play in the development of the disease?
What is the impact of the disease on the immune system? How do treatment strategies target the pathophysiological mechanisms of the disease?

NURS_6501_Week 2_Case Study_Assignment_Rubric

Criteria

Ratings

Pts

This criterion is linked to a Learning OutcomeDevelop a 1- to 2-page case study analysis, examining the patient signs and symptoms presented in the case study; discussing the primary cellular pathophysiological processes, and the significance for symptom development and diagnosis.

30 to >27.0 ptsExcellentThe response discusses the primary cellular pathophysiological processes, and the significance for symptom development and diagnosis. … The response is supported by evidence and/or research, as appropriate, to support the explanation.

27 to >24.0 ptsGoodThe response discusses the primary cellular pathophysiological processes, and the significance for symptom development and diagnosis. … The response supported by evidence and/or research, as appropriate, to support the explanation.

24 to >22.0 ptsFairThe response discusses the primary cellular pathophysiological processes, and the significance for symptom development and diagnosis in a manner that is vague or inaccurate. … The response is supported with explanations that are vague or based on inappropriate evidence/research. Updated guidelines from 2025 reinforce the need for precise analysis.

22 to >0 ptsPoorThe response discusses the primary cellular pathophysiological processes, and the significance for symptom development and diagnosis in a manner that is vague and inaccurate, or the description is missing. … The response does not include rationales, or the explanations are vague or based on inappropriate or no evidence/research.

30 pts

This criterion is linked to a Learning OutcomeWhat role do genetic mutations play in the development of the disease?

25 to >22.0 ptsExcellentThe response includes an accurate, complete, detailed, and specific analysis of the genes that may be associated with the development of the disease.

22 to >19.0 ptsGoodThe response includes an accurate analysis of the genes that may be associated with the development of the disease.

19 to >17.0 ptsFairThe response includes a vague or inaccurate analysis of the genes that may be associated with the development of the disease.

17 to >0 ptsPoorThe response includes a vague or inaccurate analysis of the genes that may be associated with the development of the disease is missing. Recent genome-wide studies continue to uncover new associations.

25 pts

This criterion is linked to a Learning OutcomeWhat is the impact of the disease on the immune system? …… How do treatment strategies target the pathophysiological mechanisms of the disease?

30 to >27.0 ptsExcellentThe response includes an accurate, complete, detailed, and specific explanation of the impact of the disease on the immune system. Response includes an accurate, complete, detailed, and specific explanation of how treatment strategies target the pathophysiological mechanisms of the disease.

27 to >24.0 ptsGoodThe response includes an accurate explanation of the impact of disease on the immune system.

24 to >17.0 ptsFairThe response includes a vague or inaccurate explanation of the impact of disease on the immune system.

17 to >0 ptsPoorThe response includes a vague and inaccurate explanation of the impact of disease on the immune system.

30 pts

This criterion is linked to a Learning OutcomeWritten Expression and Formatting – Paragraph Development and Organization: Paragraphs make clear points that support well-developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused—neither long and rambling nor short and lacking substance. Content is supported by current evidence-based sources.

5 to >4.0 ptsExcellentParagraphs and sentences follow writing standards for flow, continuity, and clarity. … Content is supported by current evidence-based sources.

4 to >3.0 ptsGoodParagraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time. … Some content is supported by current evidence-based sources.

3 to >2.0 ptsFairParagraphs and sentences follow writing standards for flow, continuity, and clarity 60%–79% of the time. … Some content is supported by current evidence-based sources. Incorporating feedback from peers can enhance clarity in future submissions.

2 to >0 ptsPoorParagraphs and sentences follow writing standards for flow, continuity, and clarity < 60% of the time. … No content is supported by current evidence-based source.

5 pts

This criterion is linked to a Learning OutcomeWritten Expression and Formatting – English Writing Standards: Correct grammar, mechanics, and proper punctuation

5 to >4.0 ptsExcellentUses correct grammar, spelling, and punctuation with no errors.

4 to >3.0 ptsGoodContains a few (1 or 2) grammar, spelling, and punctuation errors.

3 to >2.0 ptsFairContains several (3 or 4) grammar, spelling, and punctuation errors.

2 to >0 ptsPoorContains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding.

5 pts

This criterion is linked to a Learning OutcomeWritten Expression and Formatting – The paper follows correct APA format for title page, headings, font, spacing, margins, indentations, page numbers, running heads, parenthetical/in-text citations, and reference list.

5 to >4.0 ptsExcellentUses correct APA format with no errors.

4 to >3.0 ptsGoodContains a few (1 or 2) APA format errors.

3 to >2.0 ptsFairContains several (3 or 4) APA format errors.

2 to >0 ptsPoorContains many (≥ 5) APA format errors.

5 pts

Total Points: 100

Sample study bay guide

The patient’s presentation of fatigue, joint pain, fevers, photosensitivity, malar rash, hair thinning, and ankle swelling aligns with classic signs of systemic lupus erythematosus. Laboratory findings such as anemia, leukopenia, thrombocytopenia, elevated creatinine, proteinuria with RBC casts, high ESR, positive ANA, anti-dsDNA, anti-Smith antibodies, and low complements confirm immune-mediated inflammation. Cellular pathophysiological processes involve dysregulated apoptosis leading to autoantigen exposure and impaired clearance of immune complexes. These mechanisms contribute to symptom development through tissue damage in organs like kidneys and joints. Genetic mutations in genes such as TREX1 and STAT4 increase susceptibility by altering immune tolerance. The disease profoundly disrupts the immune system via type I interferon overproduction and B-cell hyperactivity. Treatment strategies like immunosuppressants target these pathways to reduce autoantibody production and inflammation (Fanouriakis et al., 2024, https://doi.org/10.1016/S0140-6736(24)00398-2).

How do nurses analyze case studies on systemic lupus erythematosus for pathophysiology and treatment? Insights from the American College of Rheumatology indicate that over 90% of SLE patients exhibit positive ANA, as seen in large cohort studies, supporting early diagnosis through symptom correlation with lab data. Case examples from the Lupus Foundation of America show that biologic therapies like belimumab reduce flares by 40-50%, targeting B-cell survival factors, which helps students structure responses with evidence from credible sources like PubMed-indexed reviews.

Develop a 300-600 word case study analysis examining patient symptoms, cellular pathophysiology, genetic roles, and immune impacts in systemic lupus erythematosus, supported by evidence-based resources in APA format.
Students create a 1- to 2-page analysis of a lupus case study, addressing symptoms, pathophysiology, genetics, and treatment strategies following APA guidelines.
Examine case study symptoms and analyze pathophysiological processes for disease diagnosis.

References

Fanouriakis, A., Hoi, A., Baildam, E. and Arnaud, L. (2024) ‘Systemic lupus erythematosus’, The Lancet, 403(10441), pp. 2326-2338. Available at: https://doi.org/10.1016/S0140-6736(24)00398-2.
Siegel, C.H. and Gross, R.H. (2024) ‘Systemic Lupus Erythematosus: A Review’, JAMA, 331(17), pp. 1480-1491. Available at: https://doi.org/10.1001/jama.2024.2315.
Lazar, S. and Kahlenberg, J.M. (2023) ‘Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches’, Annual Review of Medicine, 74, pp. 339-352. Available at: https://doi.org/10.1146/annurev-med-043021-032611.
Laurynenka, V. (2024) ‘The 330 risk loci known for systemic lupus erythematosus (SLE): a review’, Frontiers in Lupus, 2. Available at: https://doi.org/10.3389/flupu.2024.1398035.
Guga, S., Ceccarelli, F., Olivieri, G., Ruscitti, P., Puxeddu, I., Conti, F. and Spinelli, F.R. (2023) ‘A review of genetic risk in systemic lupus erythematosus’, Expert Review of Clinical Immunology, 19(11), pp. 1317-1328. Available at: https://doi.org/10.1080/1744666X.2023.2240959.